• Exchange: Indonesia
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Kalbe Farma Tbk PT

+ Add to Watchlist

KLBF:IJ

1,545 IDR 10 0.65%

As of 05:05:41 ET on 04/17/2014.

Snapshot for Kalbe Farma Tbk PT (KLBF)

Open: 1,550 Day's Range: 1,530 - 1,550 Volume: 49,387,800
Previous Close: 1,535 52wk Range: 1,110 - 1,560 1-Yr Rtn: +23.40%

Stock Chart for KLBF

No chart data available.
  • KLBF:IJ 1,545
  • 1D
  • 1M
  • 1Y
1,535
Interactive KLBF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KLBF

Current P/E Ratio (ttm) 37.7295
Estimated P/E(12/2014) 31.8557
Relative P/E vs. JCI 1.6878
Earnings Per Share (IDR) (ttm) 40.9494
Est. EPS (IDR) (12/2014) 48.5000
Est. PEG Ratio 1.9468
Market Cap (M IDR) 72,422,063.66
Shares Outstanding (M) 46,875.12
30 Day Average Volume 66,268,730
Price/Book (mrq) 8.1878
Price/Sale (ttm) 4.5258
Dividend Indicated Gross Yield 1.23%
Cash Dividend (IDR) 19.0000
Dividend Ex-Date 06/14/2013
5 Year Dividend Growth 56.87%
Next Earnings Announcement 04/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KLBF

  • Revenue
  • Net Income (M/IDR)
  • Profit Margin (%)

Company Profile & Key Executives for KLBF

PT Kalbe Farma Tbk produces and develops pharmaceutical products for human and animal healthcare. Through its subsidiaries, the Company also operates in the pharmaceutical, health food, and packaging industries.

Johannes SetijonoPresident CommissionerBernadette Ruth Irawaty SetiadyPresident Director
Budi Dharma WreksoatmodjoVice President DirectorVidjongtius VidjongtiusCFO/Director/Secretary
More Company Profile & Key Executives for KLBF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil